Aspira Women's Health Inc. (AWHL): who owns it and who trades it
As of Oct 30, 2026, AWHL insiders reported 1 purchase worth $100K in the last 12 months. The largest buyer was Jack W Schuler (10% owner), with $100K.
Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, AWHL insiders reported $100K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jack W Schuler | 10% owner | Purchase | 222,222 | $0.45 | $100K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jack W Schuler | 10% owner | $100K | – | Jun 5, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
AWHL short interest
Low short interest. Less than 0.1% of AWHL shares are sold short. Over the last 12 reports the number of shares short went down 19%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 7,285 AWHL shares were sold short, 0.0% of the shares outstanding, up 35.1% from the report before. At the average daily volume of 102,424 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 7,285 | 0.02% | +35% | 102,424 | 1.0 |
| Oct 15, 2026 | 5,393 | 0.01% | +16% | 7,997 | 1.0 |
| Sep 30, 2026 | 4,656 | 0.01% | -36% | 44,435 | 1.0 |
| Sep 15, 2026 | 7,294 | 0.02% | +61% | 30,739 | 1.0 |
| Aug 31, 2026 | 4,519 | 0.01% | -4% | 25,073 | 1.0 |
| Aug 14, 2026 | 4,711 | 0.01% | -0% | 23,068 | 1.0 |
| Jul 31, 2026 | 4,734 | 0.01% | -31% | 28,008 | 1.0 |
| Jul 15, 2026 | 6,841 | 0.02% | -24% | 21,134 | 1.0 |
| Jun 30, 2026 | 8,944 | 0.02% | -14% | 108,856 | 1.0 |
| Jun 15, 2026 | 10,364 | 0.02% | +93% | 91,953 | 1.0 |
| May 29, 2026 | 5,360 | 0.01% | -40% | 168,387 | 1.0 |
| May 15, 2026 | 8,994 | 0.02% | +60% | 95,264 | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Aspira Women's Health company events
Aspira Women's Health filed 12 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Jul 15, 2026.
- Jul 15, 2026AgreementAspira Women’s Health Inc. entered into a Subordinated Business Loan and Security Agreement with Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent, pursuant to which the Lenders (as such term is defined in the Subordinary Loan Agreement) agreed to make a… Filing
- Jul 7, 2026LeadershipAmended an earlier report. This Amendment No. 1 to Current Report on Form 8-K (this “Amendment”) amends the Current Report on Form 8-K filed by Aspira Women’s Health Inc. with the Securities and Exchange Commission on June 22, 2026, which reported, among other things, that Michael Buhle ceased serving as the Company’s Chief… Filing
- Jun 22, 2026LeadershipMichael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. Filing
- Jun 17, 2026VoteReported shareholder vote results. Filing
- Jun 9, 2026AgreementAspira Women’s Healthcare Inc. entered into securities purchase agreements with accredited and institutional investors for the issuance and sale in a private placement of (i) 3,300,000 shares of the Company’s common stock, par value $0.001 and (ii) warrants to purchase up to 4,455,000 shares of the… Filing
- May 26, 2026AgreementAspira Women’s Health Inc. announced that it had entered into a Master Collaboration and License Agreement with Cleveland Clinic Foundation, a non-profit educational, research and health care institution. Filing
- Apr 30, 2026LeadershipAspira Women's Health, Inc. appointed John Strahley as Chief Financial Officer and Chief Accounting Officer of the Company, effective April 27, 2026. Filing
- Mar 25, 2026AgreementAmended an earlier report. Aspira Women’s Health Inc. disclosed that we had entered into a Laboratory Services Agreement with Mayo Collaborative Services, Inc., d/b/a Mayo Clinic Laboratories, effective as of December 16, 2025. Filing
- Jan 30, 2026AgreementAspira Women’s Health Inc. entered into a Subordinated Business Loan and Security Agreement with Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent, pursuant to which the Lenders (as such term is defined in the Subordinary Loan Agreement) agreed to make a… Filing
- Dec 31, 2025AnnouncementShared information with investors. Filing
- Dec 23, 2025AgreementAspira Women’s Health Inc. entered into a purchase agreement with Lincoln Park Capital Fund, LLC, pursuant to which Lincoln Park committed to purchase, at the Company’s direction from time to time, up to an aggregate of $10.0 million of the Company’s common stock, par value $0.001 per share… Filing
- Dec 22, 2025AgreementAspira Women’s Health Inc. entered into a Laboratory Services Agreement with Mayo Collaborative Services, Inc., d/b/a Mayo Clinic Laboratories. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Aspira Women's Health financials
Questions about Aspira Women's Health Inc. (AWHL) stock
Are AWHL insiders buying or selling?
In the last 12 months, AWHL insiders reported 1 open-market purchase worth $100K and no sales. The latest trade was on Jun 5, 2026. See every trade.
What is the short interest in AWHL?
As of Oct 30, 2026, 7,285 AWHL shares were sold short, 0.0% of the shares outstanding, up 35.1% from the report before. At the average daily volume of 102,424 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.